Efficacy and tolerability of a prebiotic-containing multipurpose healing balm in the management of dry eczematides across phototypes, localizations and ages

F. Flament, AL. Demessant, G. Le Dantec, C. Le Floc'h

  • 10min
  • Oct. 2023
  • Supported by
  • La Roche-Posay
EADV 2023 Poster

INTRODUCTION & OBJECTIVES


Some mild cutaneous conditions do not necessarily deserve a prescription drug as a first line treatment. This is typically the case with dry eczematides for which a healing product may solve the problem with expectations including perfect tolerance, rapid calming effect and quick come back to a mark-free skin across phototypes worldwide. Evidence is growing that to restore skin microbiome plays an important role.
The objective of this study was to evaluate the efficacy and tolerability of a prebiotic-containing healing balm in the management of dry eczematides.